Furthermore, by examining the serial sections of the liver tissues of MASLD patients, we found that the expression of YBX1 in the nucleus of hepatocytes was positively correlated with that of CD36 (Figure 5E-F). This evidence concerns the gene CD36 and metabolic dysfunction-associated steatotic liver disease.